Ultimovacs Updates Timeline for Reporting on Randomized UV1 Phase II Trial INITIUM in Malignant Melanoma; Topline Results expected in March 2024
Trade with 70% Backtested Accuracy
Analyst Views on ULTI
About the author
REX Shares Names Matt Holcomb as Portfolio Manager for REX IncomeMax™ Option Strategy ETF (Ticker: ULTI)
Appointment of Portfolio Manager: REX Shares has appointed Matt Holcomb as Portfolio Manager for the newly launched REX IncomeMax™ Option Strategy ETF (ULTI), which aims to generate weekly income by writing options on volatile U.S. stocks.
Active Management Strategy: Holcomb will manage a targeted portfolio of 15 to 30 volatile equities, dynamically adjusting the strategy to market conditions to transform volatility into consistent income while managing risk.
Educational Initiative: REX is launching an educational platform where Holcomb will engage with investors through a dedicated X account, aiming to demystify options income strategies and promote transparency in investment management.
Investment Risks: The REX IncomeMax™ ETF involves significant risks, including volatility, options strategy risks, and new fund risks, making it suitable primarily for sophisticated investors who understand these complexities.
Ultimovacs ASA: Invitation to fourth quarter 2023 results webcast presentation
Ultimovacs Receives FDA Fast Track Designation for UV1 Cancer Vaccine for the Treatment of Patients with Unresectable Mesothelioma
Ultimovacs Updates Timeline for Reporting on Randomized UV1 Phase II Trial INITIUM in Malignant Melanoma; Topline Results expected in March 2024
Ultimovacs ASA: Mandatory notification of trade by primary insider
Ultimovacs ASA: Mandatory notification of trade by primary insider
REX Shares Names Matt Holcomb as Portfolio Manager for REX IncomeMax™ Option Strategy ETF (Ticker: ULTI)
Appointment of Portfolio Manager: REX Shares has appointed Matt Holcomb as Portfolio Manager for the newly launched REX IncomeMax™ Option Strategy ETF (ULTI), which aims to generate weekly income by writing options on volatile U.S. stocks.
Active Management Strategy: Holcomb will manage a targeted portfolio of 15 to 30 volatile equities, dynamically adjusting the strategy to market conditions to transform volatility into consistent income while managing risk.
Educational Initiative: REX is launching an educational platform where Holcomb will engage with investors through a dedicated X account, aiming to demystify options income strategies and promote transparency in investment management.
Investment Risks: The REX IncomeMax™ ETF involves significant risks, including volatility, options strategy risks, and new fund risks, making it suitable primarily for sophisticated investors who understand these complexities.
Ultimovacs ASA: Invitation to fourth quarter 2023 results webcast presentation
Ultimovacs Receives FDA Fast Track Designation for UV1 Cancer Vaccine for the Treatment of Patients with Unresectable Mesothelioma
Ultimovacs Updates Timeline for Reporting on Randomized UV1 Phase II Trial INITIUM in Malignant Melanoma; Topline Results expected in March 2024
Ultimovacs ASA: Mandatory notification of trade by primary insider
Ultimovacs ASA: Mandatory notification of trade by primary insider
